このアイテムのアクセス数: 121
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
j.stemcr.2024.09.008.pdf | 291.37 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | Fujita, Misao | en |
dc.contributor.author | Hatta, Taichi | en |
dc.contributor.author | Ikka, Tsunakuni | en |
dc.contributor.author | Onishi, Tatsuo | en |
dc.contributor.alternative | 藤田, みさお | ja |
dc.contributor.alternative | 八田, 太一 | ja |
dc.contributor.alternative | 一家, 綱邦 | ja |
dc.contributor.alternative | 大西, 達夫 | ja |
dc.date.accessioned | 2024-11-18T02:43:00Z | - |
dc.date.available | 2024-11-18T02:43:00Z | - |
dc.date.issued | 2024-11-12 | - |
dc.identifier.uri | http://hdl.handle.net/2433/290369 | - |
dc.description | エクソソーム治療に関する規制整備の必要性を指摘した論文が発表されました. 京都大学プレスリリース. 2024-10-25. | ja |
dc.description.abstract | Turner and colleagues recently argued that countries with unclear laws and regulations regarding stem cells, exosomes, and other regenerative medicine products should develop and enforce more comprehensive regulatory structures. We fully agree with this opinion and discuss that failure to do so may lead to troubling predicaments, such as the Japanese cases, where patients are at risk of serious complications or even death. | en |
dc.language.iso | eng | - |
dc.publisher | Elsevier BV | en |
dc.rights | © 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society for Stem Cell Research. | en |
dc.rights | This is an open access article under the CC BY-NC-ND license. | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
dc.title | The urgent need for clear and concise regulations on exosome-based interventions | en |
dc.type | journal article | - |
dc.type.niitype | Journal Article | - |
dc.identifier.jtitle | Stem cell reports | en |
dc.identifier.volume | 19 | - |
dc.identifier.issue | 11 | - |
dc.identifier.spage | 1517 | - |
dc.identifier.epage | 1519 | - |
dc.relation.doi | 10.1016/j.stemcr.2024.09.008 | - |
dc.textversion | publisher | - |
dc.address | Uehiro Research Division for iPS Cell Ethics, Center for iPS Cell Research and Application (CiRA), Kyoto University; Institute for the Advanced Study of Human Biology (WPI-ASHBi), KUIAS, Kyoto University | en |
dc.address | Graduate School of Public Health, Shizuoka Graduate University of Public Health | en |
dc.address | Division of Bioethics & Healthcare Law, Institute for Cancer Control, National Cancer Center Japan; Division of Bioethics, Center for Research Administration and Support, National Cancer Center Japan | en |
dc.address | MLIP Law Office | en |
dc.identifier.pmid | 39454583 | - |
dc.relation.url | https://www.cira.kyoto-u.ac.jp/j/pressrelease/news/241025-100000.html | - |
dcterms.accessRights | open access | - |
dc.identifier.eissn | 2213-6711 | - |
出現コレクション: | 学術雑誌掲載論文等 |

このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス